Monday, April 10, 2017 12:36:49 PM
Omni Post # 16580 Debunking Your Claims
Omni Post # 16591 - Debunked again
ROTFLMAO Generally Accepted Accounting Principles (GAAP) are not creative accounting. Your fake accounting is.
Antidilutive - Definition
This is the opposite of a dilutive transaction which causes dilution of your shares. The reduction in OS announced last week was an antidilutive transaction...
Omni Health, Inc. Converts 62% (600 Million Common Shares) of Company Common Stock into Preferred Stock in a Capitalization Restructuring
975,828,741 Outstanding Shares (OS) of common stock before restructuring
368,938,292 Outstanding Shares (OS) of common stock after restructuring.
606,890,449 shares - 62% of OS taken out of circulation.
Based on their pro forma statement in the most recent 10-Q showing earnings of $593,858 thru first 9 months minus the effect of the VitaCig sale and assuming zero earnings in 4FQ17...
New Earnings per Share (EPS) with $593,858 earnings and 368,938,741 OS = $.0016/share
Old EPS with $593,858 earnings and 975,828,741 OS = $.0006/share
New Price Earnings Ratio (PE) at $.0016 EPS and $.0232 pps ($.0232/$.0016) = 14.5x
Old PE at $.0006 EPS and $.0232 pps ($.0232/$.0006) = 38.66x
At the same PE as before the restructuring, OMHE common shares should now be re-valued at 38.66 x $.0016 or $.0618/share at the current pps
The restructuring hasn't been processed yet. We're still showing an OS of 975,828,741 on the exchanges. Once the restructuring is completed OMHE will be extremely undervalued before we even hear anything new about the company and it's plans.
NUMBERS DON'T LIE
Les
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM